文献速递肝胆胰外科围术期管理与 ERAS

可切除与可移植肝细胞癌:将肝脏硬度评估整合入决策算法

Resectable and transplantable hepatocellular carcinoma: Integration of liver stiffness assessment in the decision-making algorithm.
PubMed 文献 · Surgery · 2022-10-12

研究识别出年龄≥70岁、LSM≥11 kPa、INR≥1.2、HCC最大直径≥3 cm四个术前变量显著影响复发时间,并构建简单术前评分预测早期复发。

要点

  • 年龄≥70岁、LSM≥11 kPa、INR≥1.2、HCC最大直径≥3 cm显著影响肝切除后复发时间。
  • 评分<2分者总生存(69.7 vs 54.8个月,P=.02)和无病生存(52.2 vs 34.7个月,P=.02)优于评分≥2分者。
  • 早期复发(<1年)者术前LSM显著更高(P=.06)。

核心结论

  • 研究识别出一个简单的术前评分可预测肝切除后早期肝细胞癌复发,突显肝脏硬度的作用。
  • 该评分可帮助医生选择患者并就围术期药物治疗做出决策。

研究设计与样本

  • 采用Cox单因素回归和多因素分析构建随时间变化的复发预测评分,并通过ROC曲线联合Youden检验选择最优阈值。

主要发现

  • 平均随访40个月,复发率45%(n=30),3年总生存率88%。
  • 四个术前变量显著影响复发时间:年龄≥70岁、LSM≥11 kPa、INR≥1.2、HCC最大直径≥3 cm。
  • 每项阳性赋1分,评分<2分者(n=22)平均总生存69.7 vs 54.8个月(P=.02),无病生存52.2 vs 34.7个月(P=.02),均优于评分≥2分者。
  • 早期复发(<1年)者术前LSM显著更高(P=.06)。

关键数值与推荐

  • 评分项目:年龄≥70岁、LSM≥11 kPa、INR≥1.2、HCC最大直径≥3 cm,每项阳性计1分。
  • 评分<2分与评分≥2分分组比较总生存和无病生存。

临床怎么用

  • 可利用年龄、LSM、INR和肿瘤最大直径组成的简单术前评分识别肝切除后早期复发高风险患者。
  • 评分可能辅助患者选择和围术期药物治疗决策。

局限性

  • 早期复发与术前LSM比较的P值为.06。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Liver resection is a curative treatment for hepatocellular carcinoma (HCC) and an alternative to liver transplantation (LT). However, post-liver resection recurrence rates remain high. This study aimed to determine whether liver stiffness measurement (LSM) correlated with recurrence and to propose a method for predicting HCC recurrence exclusively using pre-liver resection criteria. METHODS: This retrospective monocentric study included patients who had undergone LR liver resection for HCC between 2015 and 2018 and who had (1) preoperative alpha-fetoprotein scores indicating initial transplant viability and (2) available preoperative LSM data. We developed a predictive score for recurrence over time using Cox univariate regression and multivariate analysis with a combination plot before selecting the optimal thresholds (receiver operating characteristic curves + Youden test). RESULTS: Sixty-six patients were included. After an average follow-up of 40 months, the recurrence rate was 45% (n = 30). Three-year overall survival was 88%. Four preoperative variables significantly impacted the time to recurrence: age ≥70 years, LSM ≥11 kPa, international normalized ratio (INR) ≥1.2, and maximum HCC diameter ≥3 cm. By assigning 1 point per positive item, patients with a score <2 (n = 22) demonstrated greater mean overall survival (69.7 vs 54.8 months, P = .02) and disease-free survival (52.2 vs 34.7 months, P = .02) than those with a score ≥2. Patients experiencing early recurrence (<1 year) presented a significantly higher preoperative LSM (P = .06). CONCLUSION: We identified a simple preoperative score predictive of early hepatocellular carcinoma recurrence after liver resection, highlighting the role of liver stiffness. This score could help physicians select patients and make decisions concerning perioperative medical treatment.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Tortajada P, Doamba R, Cano L, et al. Resectable and transplantable hepatocellular carcinoma: Integration of liver stiffness assessment in the decision-making algorithm. Surgery. 2022. PMID: 36241470. doi:10.1016/j.surg.2022.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。